EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Immunosuppressive microenvironment in acute myeloid leukemia: overview, therapeutic targets and corresponding strategies

Chenyu Zha, Xinyu Yang, Jun Yang, Yujie Zhang, Rui Huang

Annals of Hematology · 2024-12 · 103 (12) · 4883-4899

DOI: 10.1007/s00277-024-06117-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of Hematology, online erschienen am 28.11.2024. Verfasst von Chenyu Zha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Tumor Microenvironment. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 167 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Similar to other malignancies, immune dysregulation is a key feature of acute myeloid leukemia (AML), manifesting as suppressed anti-leukemia immune cells, immune evasion by leukemia blasts, and disease progression. Various immunosuppressive factors within the AML microenvironment contribute to the weakening of host immune responses and the efficacy of cellular immunotherapy. To address these challenges, strategies targeting immunosuppressive elements within the AML microenvironment aim to bolster host or adoptive immune effector cells, ultimately enhancing leukemia treatment. Additionally, the off-target effects of certain targeted drugs (venetoclax, sorafenib, ivosidenib, etc.) may also positively impact anti-AML immunity and immunotherapy. This review provides an overview of the immunosuppressive factors present in AML microenvironment and the strategies developed to rescue immune cells from immunosuppression. We also outline how targeted agents can alter the immune landscape in AML patients, and discuss the potential of targeted drugs to benefit host anti-leukemia immunity and immunotherapy for AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteTumor MicroenvironmentHumansMolecular Targeted TherapyImmunotherapy

Stichwörter der Autor:innen

Acute myeloid leukemiaImmunosuppressionImmunotherapyTargeted therapy

Autor:innen und Institutionen

  • Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China.
  • The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China.
  • Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China. rachelchn@163.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zha, C., Yang, X., Yang, J., Zhang, Y., & Huang, R. (2024). Immunosuppressive microenvironment in acute myeloid leukemia: overview, therapeutic targets and corresponding strategies. Annals of Hematology, 103(12), 4883-4899. https://doi.org/10.1007/s00277-024-06117-9

Vancouver

Zha C, Yang X, Yang J, Zhang Y, Huang R. Immunosuppressive microenvironment in acute myeloid leukemia: overview, therapeutic targets and corresponding strategies. Annals of Hematology. 2024;103(12):4883-4899. doi:10.1007/s00277-024-06117-9

BibTeX
@article{Zha2024,
  author = {Zha, Chenyu and Yang, Xinyu and Yang, Jun and Zhang, Yujie and Huang, Rui},
  title = {Immunosuppressive microenvironment in acute myeloid leukemia: overview, therapeutic targets and corresponding strategies},
  journal = {Annals of Hematology},
  year = {2024},
  volume = {103},
  number = {12},
  pages = {4883--4899},
  doi = {10.1007/s00277-024-06117-9}
}
Kostenlos starten →